You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -24.5% | 19.8% |
| ROCE | 84.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 1.2 | 1.5 |
| Price / Book value | 13.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 7.2% | -27.6% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 64.6% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 6.74 | -0.65 | -1.50p | -44.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 10.09 | 0.25 | 1.40p | 90.4 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 12.61 | -0.62 | -1.30p | -87.7 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 13.52 | -3.46 | -10.10p | -5.1 | 0.0 | n/a | n/a | 0.0% |
| Cambridge Cognition product used in schizophrenia treatment trial Sharecast News | 08 Jan |
|---|---|
| Cambridge Cognition FY revenues seen at no less than £10m Sharecast News | 10 Dec |
| Cambridge Cognition ex-CEO resigns as director Sharecast News | 18 Oct |
| Board Appointment | 07-Feb-25 07:01 |
|---|---|
| Launch of in-house rater training service | 21-Jan-25 07:01 |
| Expanded partnership with Actinogen | 16-Jan-25 07:01 |
| Director/PDMR Share Purchases | 27-Dec-24 15:34 |
| Director/PDMR Share Purchases | 23-Dec-24 16:02 |